You are correct! "Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that the Food and Drug Administration (FDA) has granted Fast Track Designation for the company’s immunotherapy product candidate ADXS-HER2 for patients with newly-diagnosed, non-metastatic, surgically-resectable osteosarcoma."
Not his fault. He was almost flushed away by his mother when he was lepetite_merde but he managed to cling to the side of the bowl.
You cant. It's just the voices in his head telling him. He/she needs to adjust the meds.
If AEZS succeeds, it will be by sheer luck and not through the skill of management. That said, I don't think the prospects for Zoptrex are bad but management has proved to be totally inept at navigating the FDA process.
The cervical indication is the one I would like to see partnered, licensed, financed...whatever! Having cash on hand from a deal would give the company more leverage and credibility. The potential is there to take the PPS to new heights. Dan presents himself very well from the calls I have heard. Now it's time to go to the Cantor Fitzgerald conference, network and make the deal(s).
There isn't a worse service out there for investors who are looking to capitalize on the undervalued and overlooked opportunities from across the markets, these guys just keep delivering losing reports to their sad, destitute members.
Lets review the facts:
You're an idiot.
Bogus is an idiot.
Mikey (and a few more) are idiots.
Do you all shack up in Mikey's trailer?
There isn't a worse service out there for investors who are looking to capitalize on the undervalued and overlooked opportunities from across the markets, these guys just keep delivering losing reports to their broke members.
I can't believe I'm voting this year for who will do the less harm. What a way to cast a vote. I remember voting for whom I thought could do the best job. Those days seem long ago.